Skip to main content
Aplab Ltd. logo

Aplab Ltd. — Investor Relations & Filings

Ticker · 890217 ISIN · IN9273A01047 LEI · 3358005DVRNWJLJH2Y24 BSE.NS Manufacturing
Open in API
Filings indexed 351 across all filing types
Latest filing 2023-11-09 Regulatory Filings
Country IN India
Listing BSE.NS 890217

About Aplab Ltd.

https://www.aplab.com

Aplab Ltd. specializes in the design, manufacture, and marketing of professional electronic equipment. The product portfolio includes test and measurement instruments, power conversion and control systems, uninterruptible power supplies (UPS), and solar power solutions. The company also provides specialized hardware for banking and retail automation, including automated teller machines and self-service kiosks. Serving sectors such as defense, telecommunications, education, and industrial manufacturing, the organization focuses on research and development to deliver high-precision laboratory instruments and robust power electronics. Its solutions encompass smart card-based systems and specialized power supplies for critical infrastructure, emphasizing technical reliability and engineering excellence.

Recent filings

Filing Released Lang Actions
Approval of un-audited financial results for the quarter and half year ended 30th September, 2023 and other matters.
Regulatory Filings
2023-11-09 English
Outcome of Board Meeting held on 9th November, 2023 for approval of unaudited financial results for the quarter and half year ended 30th September, 2023 and other matters.
Regulatory Filings Classification · 95% confidence The document is a formal communication from the company to the stock exchange regarding the outcome of a board meeting held on November 9, 2023. It announces the approval of un-audited financial results for the second quarter and half year ended September 30, 2023, and mentions a limited review report by statutory auditors on these results. The document is short (1349 characters) and serves as an announcement of the approval and publication of the financial results rather than containing the full financial statements or detailed analysis itself. Therefore, it is not the full Interim/Quarterly Report (IR) but an announcement of the results and related documents. Given the nature and length, this fits best under Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other categories.
2023-11-09 English
APLAB LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/11/2023 ,inter alia, to consider and approve the Un-audited financial results for ....
Regulatory Filings Classification · 95% confidence The document is a short notice informing about the convening of a Board Meeting to take on record the unaudited financial results for the second quarter and half year ended September 30, 2023. It references regulatory compliance under SEBI (LODR) Regulations and insider trading regulations. The document does not contain the financial results themselves, only the announcement of the meeting where these results will be considered and approved. The length is only 1170 characters, indicating it is an announcement rather than a full report. Therefore, this fits the category of a Regulatory Filing (RNS) as it is a general regulatory announcement and does not contain substantive financial data or the actual report.
2023-10-30 English
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Amrita Prabhakar Deodhar & PACs
Regulatory Filings
2023-10-25 English
Closure of Trading Window for the un-audited financial results for the second quarter and half year ended 30th September, 2023.
Regulatory Filings Classification · 95% confidence The document is a short notice informing about the closure of the trading window for insiders ahead of the announcement of unaudited financial results for the second quarter and half year ended September 30, 2023. It references regulatory compliance with SEBI insider trading regulations and mentions the upcoming board meeting date will be intimated later. The document does not contain any financial data or results itself, nor does it present a report. It is an announcement related to trading restrictions prior to financial results disclosure. Given the short length (1434 characters) and the nature of the content, this fits best as a Regulatory Filing (RNS) rather than an Interim Report (IR) or Earnings Release (ER).
2023-10-06 English
Compliance Certificate for the quarter ended 30th September, 2023 under regulation 74(5) of SEBI
Regulatory Filings Classification · 95% confidence The document is a certificate pursuant to Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, confirming compliance for the quarter ended 30th September 2023. It is a confirmation certificate issued by the Registrar and Share Transfer Agents, confirming dematerialisation and related compliance. The document is short (2595 characters) and primarily serves as a compliance certification rather than a financial report or announcement of financial results. It does not contain financial statements or detailed financial data. It is not an announcement of a report but a regulatory compliance certificate. Therefore, it fits best under Regulatory Filings (RNS), which covers officer certifications, attestations, and miscellaneous regulatory documents that do not fit other categories.
2023-10-06 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.